Disagree
Home Pharmaqo Labs Pharmaqo Labs
TB-500
TB-500 - Pharmaqo Labs

TB-500 - Pharmaqo Labs

Brand:
Category:
Substance:
Package:
10 mg
Price:
0
See options
Product Overview

Thymosin Beta-4 (Tβ4) is an endogenous peptide known for its healing properties, especially in response to injury. TB-500, a part of Tβ4, is particularly active in promoting tissue repair through blood vessel growth, aiding the recovery of the heart, skin, and ligaments. By reducing inflammation and supporting immune function, TB4 provides significant benefits in managing injuries. This peptide is highly concentrated in organs like the thymus, lungs, and spleen, and is also present in bodily fluids, playing a versatile role in the body.

References:

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about TB-500 by Pharmaqo Labs, consult with your doctor or healthcare professional.

Explore More Products
FAQ
What are beta thymosins?
Beta thymosins are a family of conserved acidic peptides, originally thought to be thymic hormones, that support various biological functions.
References:

Maar, K., Hetenyi, R., Maar, S., Faskerti, G., Hanna, D., Lippai, B., Takatsy, A., Bock-Marquette, I. and Jin, K., 2021. Utilizing developmentally essential secreted peptides such as thymosin beta-4 to remind the adult organs of their embryonic state—New directions in anti-aging regenerative therapies. Frontiers in Molecular Biosciences.

How many beta thymosins exist, and how many are in humans?
There are sixteen known beta thymosins, three of which—Thymosin β4 (TB4), Thymosin β10 (TB10), and Thymosin β15 (TB15)—are present in humans.
References:

Maar, K., Hetenyi, R., Maar, S., Faskerti, G., Hanna, D., Lippai, B., Takatsy, A., Bock-Marquette, I. and Jin, K., 2021. Utilizing developmentally essential secreted peptides such as thymosin beta-4 to remind the adult organs of their embryonic state—New directions in anti-aging regenerative therapies. Frontiers in Molecular Biosciences.

Who discovered beta thymosins, and when?
A.L. Goldstein and A. White first described beta thymosins in 1966.
References:

Maar, K., Hetenyi, R., Maar, S., Faskerti, G., Hanna, D., Lippai, B., Takatsy, A., Bock-Marquette, I. and Jin, K., 2021. Utilizing developmentally essential secreted peptides such as thymosin beta-4 to remind the adult organs of their embryonic state—New directions in anti-aging regenerative therapies. Frontiers in Molecular Biosciences.